IQVIA™ Real-World Insights Bibliography

Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
Author(s): Sean Wharton1, Aiden Liu2, Arash Pakseresht2, Emil N?rtoft3, Christiane L. Haase3, Johanna Mancini4, G. Sarah Power5, Sarah Vanderlelie1, and Rebecca A. G. Christensen1
Affiliations(s): 1 Wharton Medical Clinic, Burlington, Canada. Correspondence: Sean Wharton (wharton@whartonmedicalclinic.com) 2 Novo Nordisk Canada Inc., Mississauga, Canada 3 Novo Nordisk A/S, S?borg, Denmark 4 IQVIA, Kirkland, Canada 5 IQVIA, Mississauga, Canada.
Publication(s):  Obesity (Silver Spring). 2019 Jun;27(6):917-924. doi: 10.1002/oby.22462. Epub 2019 May 7.
Document Type(s): Article,
Countries: Canada, Nordic,
Click here for the abstract
C:
Y:
Obesity,
2019
  L:
A:
English
  Add to report
 
 
Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
Author(s): Larsson K, Ställberg B, Lisspers K, Telg G, Johansson G, Thuresson M, Janson C
Affiliations(s): Work Environment Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Publication(s):  Respiratory Research (2018) 19:12
Document Type(s): Article,
Countries: Nordic, Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2018
  L:
A:
English
Clinical setting: Primary care, Epidemiological study, Observational study, Population Based Study,
  Add to report
 
 
Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR)
Author(s): Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Larsson K
Affiliations(s): Respiratory, Allergy and Sleep Research, Dept of Medical Sciences, Uppsala University, Uppsala, Sweden
Publication(s):  European Respiratory Journal (2018) 52: 1701927
Document Type(s): Article,
Countries: Nordic, Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2018
  L:
A:
English
Clinical setting: Primary care, Epidemiological study, Observational study, Population Based Study,
  Add to report
 
 
Total cost of health care resource utilization for asthma patients in Sweden with different exposures to oral corticosteroids
Author(s): Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Christensen H, Larsson K
Affiliations(s): Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Sweden
Publication(s):  Allergy. European Journal of Allergy and Clinical Immunology, Vol. 73, no Suppl.105, p. 529-529
Document Type(s): Abstract,
Countries: Nordic, Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2018
  L:
A:
English
Clinical setting: Primary care, Cost analysis,
  Add to report
 
 
Different patterns of second?line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study
Author(s): Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW
Affiliations(s): StatFinn & EPID Research, Espoo, Finland
Publication(s):  Endocrinol Diabetes Metab.
Document Type(s): Article,
Countries: Denmark, Finland, Nordic, Norway, Sweden,
Click here for the abstract
C:
Y:
Diabetes,
2018
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
#4018 Treatment patterns in patients (pts) with stage IIIB-IV non-small cell lung cancer (NSCLC) in Sweden: The SCAN-LEAF study
Author(s): Simon Ekman,Maria Planck, Jens Benn Sørensen, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarez-Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun
Affiliations(s): Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden; Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium, Department of Oncology, Radiumhospitalet, Oslo, Norway
Publication(s): 
Document Type(s): Poster,
Countries: Nordic, UK,
C:
Y:

2018
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden.
Author(s): Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2.
Affiliations(s): Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2. 1 IQVIA , London , UK. 2 Swedish Orphan Biovitrum AB , Stockholm , Sweden.
Publication(s): 
Document Type(s): Article,
Countries: Nordic, UK,
C:
Y:
Hematology, Rare disease,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Can patients accurately report their drugs? -A comparison of self-reported medication with a national register in Denmark in a subset of the protect pregnancy cohort.
Author(s): Bourke A, Laursen M, Dreyer N, Hallgreen CE, Blackburn S
Affiliations(s): 
Publication(s):  Pharmacoepidemiol Drug Saf 2018; 27 (2):87
Document Type(s): Poster,
Countries: Nordic,
C:
Y:
Pregnancy, Womens Health,
2018
  L:
A:
English
  Add to report
 
 
#2811 Initial treatment in patients (pts) diagnosed with non-small cell lung cancer (NSCLC) in Denmark from 2005-2015: The SCAN-LEAF study
Author(s): Jens Benn Sørensen, Simon Ekman, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarez‐Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun, Maria Planck
Affiliations(s): Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium; Department of Oncology, Radiumhospitalet, Oslo, Norway; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden
Publication(s): 
Document Type(s): Poster,
Countries: England, Nordic, UK,
C:
Y:
Oncology,
2018
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Predictors and diseasburden of ulcerative colitis progression in Sweden.
Author(s): Stålhammar J1,Hällström P1, Agreus L2, Beydogan H3, Arnheim Dahlström L3, Skup M4, Lee W-J4
Affiliations(s): 1 Uppsala University, Uppsala, Sweden 2 Karolinska Institutet, Stockholm, Sweden 3 QuintilesIMS, Stockholm, Sweden 4 AbbVie Inc., North Chicago, USA.
Publication(s):  UEG Barcelona September 2017
Document Type(s): Abstract,
Countries: Nordic, Sweden,
C:
Y:
Immunology and Vaccination,
2017
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
First Page Previous Page  2 of 11 Next Page Last Page